Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Eberl

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Nature Biotechnology|January 22, 2020
Identifying drug targets in tissues and whole blood with thermal-shift profilingJessica Perrin, Thilo Werner, Nils Kurzawa, et al.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Journal of Medicinal Chemistry|August 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and SafetyJoseph E Pero, Elizabeth A Mueller, Ashley M Adams, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Nature Biotechnology|January 22, 2020
Identifying drug targets in tissues and whole blood with thermal-shift profilingJessica Perrin, Thilo Werner, Nils Kurzawa, et al.
Cancer Research Communications|July 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway ModulationAnna Rutkowska, H Christian Eberl, Thilo Werner, et al.
Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.
Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.
Journal of Medicinal Chemistry|August 13, 2024
Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and SafetyJoseph E Pero, Elizabeth A Mueller, Ashley M Adams, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 4